Among the key features of the new framework are “super-grouping” of variations, a risk-based approach to classifying changes to biological products, and a more streamlined approach to updating pandemic vaccines.
New EU rules that will allow variations to marketing authorizations to be processed more quickly are due to take effect at the beginning of 2025 after the European Commission adopted a “delegated regulation” amending the current variations regulation (No 1234/2008).
The changes, which the commission said would reduce the burden on both marketing authorization holders (MAHs) and regulatory authorities, are...
Create an account to read this article
Already a subscriber?
Arimoclomol, Zevra Therapeutics's treatment for Niemann-Pick disease Type C, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
If approved, Sanofi’s acoziborole could become the first single-dose oral treatment for sleeping sickness.
Biogen has U-turned on its original decision not to file Qalsody for marketing approval in the UK for treating certain patients with amyotrophic lateral sclerosis. The move appears to have been triggered by a change in the reimbursement pathway agreed for the product.
A task force set up by the EMA to identify and prioritize improvements to the Clinical Trials Information System has recommended several measures to enhance CTIS’ usability and efficiency, including the potential introduction of a communication tool for direct sponsor-assessor interaction.
The new 60-day deadline for striking a deal with the drug industry underscores the challenges the Administration may be having in developing non-voluntary policies to achieve MFN pricing in the US.
Pilot is harbinger of greater transparency in the 340B program. But rebates may only be denied by manufacturers for overlap with Medicare negotiated prices, not for issues like diversion that have driven recent lawsuits.
If approved, Sanofi’s acoziborole could become the first single-dose oral treatment for sleeping sickness.
